These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17137470)

  • 1. Long-term effects of hemostatic variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I).
    De Stavola BL; Meade TW
    J Thromb Haemost; 2007 Mar; 5(3):461-71. PubMed ID: 17137470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term association of routine blood count (Coulter) variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I).
    Pizzi C; De Stavola BL; Meade TW
    Int J Epidemiol; 2010 Feb; 39(1):256-65. PubMed ID: 19596751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skinfold thickness, body mass index, and fatal coronary heart disease: 30 year follow up of the Northwick Park heart study.
    Kim J; Meade T; Haines A
    J Epidemiol Community Health; 2006 Mar; 60(3):275-9. PubMed ID: 16476761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of seasonal patterns in hemostatic factors in older men and their relation to excess winter coronary heart disease deaths.
    Ghebre MA; Wannamethee SG; Rumley A; Whincup PH; Lowe GD; Morris RW
    J Thromb Haemost; 2012 Mar; 10(3):352-8. PubMed ID: 22235876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.
    Meade TW; Mellows S; Brozovic M; Miller GJ; Chakrabarti RR; North WR; Haines AP; Stirling Y; Imeson JD; Thompson SG
    Lancet; 1986 Sep; 2(8506):533-7. PubMed ID: 2875280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic factors as predictors of coronary events and total mortality: The FINRISK '92 Hemostasis Study.
    Salomaa V; Rasi V; Kulathinal S; Vahtera E; Jauhiainen M; Ehnholm C; Pekkanen J
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):353-8. PubMed ID: 11834541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopausal status and haemostatic variables.
    Meade TW; Haines AP; Imeson JD; Stirling Y; Thompson SG
    Lancet; 1983 Jan; 1(8314-5):22-4. PubMed ID: 6129369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: prospective cohort study from the screening phase of the Thrombosis Prevention Trial.
    Rudnicka AR; Mt-Isa S; Meade TW
    J Thromb Haemost; 2006 Nov; 4(11):2405-10. PubMed ID: 17002654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen and factor VIIc levels: independent risk factors or markers of coronary disease risk?
    Donati MB; Iacoviello L
    J Thromb Haemost; 2007 Mar; 5(3):458-60. PubMed ID: 17229049
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men.
    Heinrich J; Balleisen L; Schulte H; Assmann G; van de Loo J
    Arterioscler Thromb; 1994 Jan; 14(1):54-9. PubMed ID: 8274478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Northwick Park Heart Study: evidence from the laboratory.
    Ten Cate H; Meade T
    J Thromb Haemost; 2014 May; 12(5):587-92. PubMed ID: 24593861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease.
    Meade TW; Imeson J; Stirling Y
    Lancet; 1987 Oct; 2(8566):986-8. PubMed ID: 2889958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Northwick Park Heart Studies: contrasts between the two factor VII assays used.
    Meade TW; Stirling Y
    J Thromb Haemost; 2012 Mar; 10(3):482-4. PubMed ID: 22235852
    [No Abstract]   [Full Text] [Related]  

  • 14. Coagulation factor VII and the risk of coronary heart disease in healthy men.
    Junker R; Heinrich J; Schulte H; van de Loo J; Assmann G
    Arterioscler Thromb Vasc Biol; 1997 Aug; 17(8):1539-44. PubMed ID: 9301633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDL cholesterol predicts coronary heart disease mortality in older persons.
    Corti MC; Guralnik JM; Salive ME; Harris T; Field TS; Wallace RB; Berkman LF; Seeman TE; Glynn RJ; Hennekens CH
    JAMA; 1995 Aug; 274(7):539-44. PubMed ID: 7629981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women. The Scottish Heart Health Study.
    Woodward M; Lowe GD; Rumley A; Tunstall-Pedoe H
    Eur Heart J; 1998 Jan; 19(1):55-62. PubMed ID: 9503176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men.
    Wannamethee SG; Whincup PH; Shaper AG; Rumley A; Lennon L; Lowe GD
    J Thromb Haemost; 2009 Oct; 7(10):1605-11. PubMed ID: 19682232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemostatic function and cardiovascular death: early results of a prospective study.
    Meade TW; North WR; Chakrabarti R; Stirling Y; Haines AP; Thompson SG; Brozovié M
    Lancet; 1980 May; 1(8177):1050-4. PubMed ID: 6103391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostatic variables in the prediction of coronary risk: results of the 8 year follow-up of healthy men in the Münster Heart Study (PROCAM). Prospective Cardiovascular Münster Study.
    Assmann G; Cullen P; Heinrich J; Schulte H
    Isr J Med Sci; 1996 Jun; 32(6):364-70. PubMed ID: 8682642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
    ; Danesh J; Lewington S; Thompson SG; Lowe GD; Collins R; Kostis JB; Wilson AC; Folsom AR; Wu K; Benderly M; Goldbourt U; Willeit J; Kiechl S; Yarnell JW; Sweetnam PM; Elwood PC; Cushman M; Psaty BM; Tracy RP; Tybjaerg-Hansen A; Haverkate F; de Maat MP; Fowkes FG; Lee AJ; Smith FB; Salomaa V; Harald K; Rasi R; Vahtera E; Jousilahti P; Pekkanen J; D'Agostino R; Kannel WB; Wilson PW; Tofler G; Arocha-Piñango CL; Rodriguez-Larralde A; Nagy E; Mijares M; Espinosa R; Rodriquez-Roa E; Ryder E; Diez-Ewald MP; Campos G; Fernandez V; Torres E; Marchioli R; Valagussa F; Rosengren A; Wilhelmsen L; Lappas G; Eriksson H; Cremer P; Nagel D; Curb JD; Rodriguez B; Yano K; Salonen JT; Nyyssönen K; Tuomainen TP; Hedblad B; Lind P; Loewel H; Koenig W; Meade TW; Cooper JA; De Stavola B; Knottenbelt C; Miller GJ; Cooper JA; Bauer KA; Rosenberg RD; Sato S; Kitamura A; Naito Y; Palosuo T; Ducimetiere P; Amouyel P; Arveiler D; Evans AE; Ferrieres J; Juhan-Vague I; Bingham A; Schulte H; Assmann G; Cantin B; Lamarche B; Després JP; Dagenais GR; Tunstall-Pedoe H; Woodward M; Ben-Shlomo Y; Davey Smith G; Palmieri V; Yeh JL; Rudnicka A; Ridker P; Rodeghiero F; Tosetto A; Shepherd J; Ford I; Robertson M; Brunner E; Shipley M; Feskens EJ; Kromhout D; Dickinson A; Ireland B; Juzwishin K; Kaptoge S; Lewington S; Memon A; Sarwar N; Walker M; Wheeler J; White I; Wood A
    JAMA; 2005 Oct; 294(14):1799-809. PubMed ID: 16219884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.